Amneal Pharmaceuticals Inc (AMRX.N)

AMRX.N on New York Stock Exchange

1:30am IST
Change (% chg)

$-0.09 (-3.15%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Amneal Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and marketing of bioequivalent pharmaceutical products (generics), in addition to the development and marketing of branded products. It operates in two segments, which include Generics and Specialty Pharma.... (more)


Beta: 1.03
Market Cap(Mil.): $1,620.01
Shares Outstanding(Mil.): 74.31
Dividend: --
Yield (%): --


  AMRX.N Industry Sector
P/E (TTM): -- 29.89 32.67
EPS (TTM): -8.08 -- --
ROI: -39.49 14.89 14.48
ROE: -72.27 16.01 15.78

Amneal cuts forecast as epinephrine shot supply issues linger, shares slump 36%

Shares of Amneal Pharmaceuticals Inc plunged 36% to an all-time low on Wednesday after the generic drugmaker cut its 2019 core earnings forecast due to supply uncertainties related to its epinephrine auto-injectors.

11 Jul 2019

Amneal Pharma slashes core earnings forecast on allergy shot supply issues

July 10 Amneal Pharmaceuticals Inc on Wednesday cut its core earnings forecast for the year, citing uncertainty in supply of epinephrine auto-injectors amid a global shortage of the emergency allergy shots, including Mylan NV's EpiPen.

10 Jul 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates